Optimization of detection of circulating tumor cells by flow cytometry and qRT-PCR

Authors

  • Katarzyna Pogoda Department of Human Immunology, Institute for Experimental and Clinical Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland; Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0003-3852-7548
  • Paweł Rybojad Department of Thoracic Surgery, 2 Faculty of Medicine, Medical University of Lublin, Lublin, Poland https://orcid.org/0000-0003-4333-8979
  • Inés Ramírez Álvarez Students’ Scientific Association at Department of Clinical Immunology, 2nd Faculty of Medicine, Medical University of Lublin, Lublin, Poland https://orcid.org/0000-0002-0374-2611
  • Thusyanthan Mohanathas Students’ Scientific Association at Department of Clinical Immunology, 2nd Faculty of Medicine, Medical University of Lublin, Lublin, Poland https://orcid.org/0000-0003-2167-009X
  • Sarah Hosseini Students’ Scientific Association at Department of Clinical Immunology, 2nd Faculty of Medicine, Medical University of Lublin, Lublin, Poland https://orcid.org/0000-0002-4094-2057
  • Jacek Tabarkiewicz Department of Human Immunology, Institute for Experimental and Clinical Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland; Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-1264-2882

DOI:

https://doi.org/10.15584/ejcem.2019.1.1

Keywords:

circulating tumor cells, flow cytometry, PCR

Abstract

Introduction. Treatment and diagnostic process in solid tumors like lung cancer are still based on invasive methods such as bronchoscopy, solid biopsy et cetera. One of the less invasive methods is a proposed “liquid biopsy” which is based on capturing of tumor cells circulating in the blood.

Aim. The aim of the study was to standardize conditions and to assess the sensitivity of the identification of circulating tumor cells (CTCs) with the use of flow cytometry and qRT-PCR.

Material and methods. In the first model of CTCs, cells from the A549 lung cancer cell line were suspended in 1 ml of healthy donors’ blood in 5 spikes increasingly: 0, 10, 50, 100 and 200 and the cells were detected in flow cytometer. In the second model, cells from the A549 and H1975 lung cancer cell lines were used. Spikes were prepared as in the first model, but cells were suspended in 400 µl of healthy donors’ blood and were detected with the use of qRT-PCR.

Results. An increasing number of detected cytokeratin positive events from the 1st spike “0” to the last one - “200” was observed by flow cytometry. Median value in the negative control was 0 false positive cells. In tubes from “10” to “200” the median was 5, 43.5, 58 and 78, respectively. Mean sensitivity of flow cytometry was 63.79%. In qRT-PCR, correlation between increasing number of sorted cells in several spikes and the level of mRNA expression for KRT19 gene was not observed.

Conclusion. Commonly available methods like flow cytometry and qRT-PCR seem to be attractive solutions for CTCs detection, but they need pre-enrichment procedures and standardization. 

Downloads

Download data is not yet available.

References

Li Y, Wu S, Bai F. Molecular characterization of circulating tumor cells—from bench to bedside. Semin Cell Dev Biol. 2018;75:88-97.

Watanabe S. The metastasizability of tumor cells. Cancer. 1954;7(2):215-223.

Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192(3):373-382.

Gkountela S, Szczerba B, Donato C, Aceto N. Recent advances in the biology of human circulating tumour cells and metastasis. ESMO Open. 2016;1(4):e000078.

Arvelo F, Sojo F, Cotte C. Cancer and the metastatic substrate. Ecancermedicalscience. 2016;10:701.

Hong Y, Fang F, Zhang Q. Circulating tumor cell clusters: What we know and what we expect (Review). Int J Oncol. 2016;49(6):2206-2216.

Grover PK, Cummins AG, Price TJ, Roberts-Thomson IC, Hardingham JE. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol. 2014;25(8):1506-1516.

Schlange T, Pantel K. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy. Pharmacogenomics. 2016;17(3):183-186.

Miller MC, Doyle G V, Terstappen LWMM. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol. 2010;2010:617421.

Ferreira MM, Ramani VC, Jeffrey SS. Circulating tumor cell technologies. Mol Oncol. 2016;10(3):374-394.

Lin M, Chen J-F, Lu Y-T, et al. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Acc Chem Res. 2014;47(10):2941-2950.

Low WS, Wan Abas WAB, Low WS, Wan Abas WAB. Benchtop Technologies for Circulating Tumor Cells Separation Based on Biophysical Properties. Biomed Res Int. 2015;2015:1-22.

Gabriel MT, Calleja LR, Chalopin A, Ory B, Heymann D. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. Clin Chem. 2016;62(4):571-81.

Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1-11.

Lustberg M, Jatana KR, Zborowski M, Chalmers JJ. Emerging technologies for CTC detection based on depletion of normal cells. Recent Results Cancer Res. 2012;195:97-110.

Xu Y, Qin T, Li J, et al. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. Int J Mol Sci. 2017;18(4).

Takao M, Takeda K. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry. Cytom Part A. 2011;79A(2):107-117.

Lu Y, Liang H, Yu T, et al. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry. Cancer. 2015;121(17):3036-3045.

Yin J, Wang Y, Yin H, et al. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application. PLoS One. 2015;10(8):e0137076.

Fu X, Shen C, Wang H, Chen F, Li G, Wen Z. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance. BMC Cancer. 2017;17(1):479.

Yin C, Wang Y, Ji J, et al. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device. Anal Chem. 2018;90(6):3744-3751.

Bao H, Burke PA, Huang J, et al. Circulating Tumor Cells: Application as a Biomarker for Molecular Characterization and Predictor of Survival in an All-Comer Solid Tumor Phase I Clinical Study. PLoS One. 2013;8(8):e58557.

Guo W, Yang X-R, Sun Y-F, et al. Clinical Significance of EpCAM mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR-Based Platform. Clin Cancer Res. 2014;20(18):4794-4805.

Ning Y, Hanna DL, Zhang W, et al. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach. Mol Cancer Ther. 2015;14(10):2401-2408.

Koren, Ana Sodja, Eva Rijavec, Matija Jez, Mojca Kovac, Viljem Korosec, Peter Cufer T. Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients. Cell Oncol. 2015;38:387-395.

Politaki E, Agelaki S, Apostolaki S, et al. A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer. Cell Physiol Biochem. 2017;44(2):594-606.

Tartarone A, Rossi E, Lerose R, et al. Possible applications of circulating tumor cells in patients with non small cell lung cancer. Lung Cancer. 2017;107:59-64.

Hanssen A, Loges S, Pantel K, Wikman H. Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer. Front Oncol. 2015;5(September):1-5.

Huang HB, Ge MJ. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer. Thorac Cardiovasc Surg. 2016;64(6):515-519.

Downloads

Published

2019-03-30

How to Cite

Pogoda, K., Rybojad, P., Álvarez, I. R., Mohanathas, T., Hosseini, S., & Tabarkiewicz, J. (2019). Optimization of detection of circulating tumor cells by flow cytometry and qRT-PCR. European Journal of Clinical and Experimental Medicine, 17(1), 5–11. https://doi.org/10.15584/ejcem.2019.1.1

Issue

Vol. 17 No. 1 (2019)

Section

ORIGINAL PAPERS

License

Copyright (c) 2019 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.